▶ 調査レポート

世界の結核検査・診断市場規模・現状・予測(2021年-2027年)

• 英文タイトル:Global Tuberculosis Testing and Diagnostics Market Size, Status and Forecast 2021-2027

QYResearchが調査・発行した産業分析レポートです。世界の結核検査・診断市場規模・現状・予測(2021年-2027年) / Global Tuberculosis Testing and Diagnostics Market Size, Status and Forecast 2021-2027 / QYR2104Z6211資料のイメージです。• レポートコード:QYR2104Z6211
• 出版社/出版日:QYResearch / 2021年4月10日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、133ページ
• 納品方法:Eメール(納期:3日)
• 産業分類:医療
• 販売価格(消費税別)
  Single User¥577,200 (USD3,900)▷ お問い合わせ
  Multi User/Five User¥865,800 (USD5,850)▷ お問い合わせ
  Enterprise License(同一法人内共有可)¥1,154,400 (USD7,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
QYResearch社発行の本調査資料では、結核検査・診断のグローバル市場(2016年~2027年)について調べ、市場動向、主要企業の市場シェア、種類別市場規模(塗抹顕微鏡検査、核酸検査、X線撮影、ツベルクリン皮膚検査(TST)、インターフェロンガンマ放出アッセイ(IGRA)、その他)、用途別市場規模(病院・診療所、診断研究所、その他)、主要地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、関連企業情報などを掲載しています。
・市場概要
・結核検査・診断の市場動向
・企業の競争状況、市場シェア
・結核検査・診断の種類別市場規模(塗抹顕微鏡検査、核酸検査、X線撮影、ツベルクリン皮膚検査(TST)、インターフェロンガンマ放出アッセイ(IGRA)、その他)
・結核検査・診断の用途別市場規模(病院・診療所、診断研究所、その他)
・結核検査・診断の北米市場規模2016-2027(アメリカ、カナダ)
・結核検査・診断のヨーロッパ市場規模2016-2027(ドイツ、フランス、イギリス等)
・結核検査・診断のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・結核検査・診断の中南米市場規模2016-2027(メキシコ、ブラジル)
・結核検査・診断の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Roche、Thermo Fischer Scientific、Becton Dickinson、Abbott、Hologic、Qiagen、Sanofi、Oxford Immunotec、BioMerieux、Par Sterile、Bio-Rad Laboratories、Akonni Biosystems、Cepheid、Siemens Healthineer、Hain Lifescience、Epistem、Creative Diagnostics)
・結論

Market Analysis and Insights: Global Tuberculosis Testing and Diagnostics Market
The global Tuberculosis Testing and Diagnostics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Tuberculosis Testing and Diagnostics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Tuberculosis Testing and Diagnostics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Tuberculosis Testing and Diagnostics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Tuberculosis Testing and Diagnostics market.

Global Tuberculosis Testing and Diagnostics Scope and Market Size
Tuberculosis Testing and Diagnostics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Tuberculosis Testing and Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Smear Microscopy
Nucleic Acid Testing
Radiography
Tuberculin Skin Test (TST)
Interferon Gamma Released Assay (IGRA)
Others

Segment by Application
Hospitals and Clinics
Diagnostic Laboratories
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Roche
Thermo Fischer Scientific
Becton Dickinson
Abbott
Hologic
Qiagen
Sanofi
Oxford Immunotec
BioMerieux
Par Sterile
Bio-Rad Laboratories
Akonni Biosystems
Cepheid
Siemens Healthineer
Hain Lifescience

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Tuberculosis Testing and Diagnostics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Smear Microscopy
1.2.3 Nucleic Acid Testing
1.2.4 Radiography
1.2.5 Tuberculin Skin Test (TST)
1.2.6 Interferon Gamma Released Assay (IGRA)
1.2.7 Others
1.3 Market by Application
1.3.1 Global Tuberculosis Testing and Diagnostics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals and Clinics
1.3.3 Diagnostic Laboratories
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Tuberculosis Testing and Diagnostics Market Perspective (2016-2027)
2.2 Tuberculosis Testing and Diagnostics Growth Trends by Regions
2.2.1 Tuberculosis Testing and Diagnostics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Tuberculosis Testing and Diagnostics Historic Market Share by Regions (2016-2021)
2.2.3 Tuberculosis Testing and Diagnostics Forecasted Market Size by Regions (2022-2027)
2.3 Tuberculosis Testing and Diagnostics Industry Dynamic
2.3.1 Tuberculosis Testing and Diagnostics Market Trends
2.3.2 Tuberculosis Testing and Diagnostics Market Drivers
2.3.3 Tuberculosis Testing and Diagnostics Market Challenges
2.3.4 Tuberculosis Testing and Diagnostics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Tuberculosis Testing and Diagnostics Players by Revenue
3.1.1 Global Top Tuberculosis Testing and Diagnostics Players by Revenue (2016-2021)
3.1.2 Global Tuberculosis Testing and Diagnostics Revenue Market Share by Players (2016-2021)
3.2 Global Tuberculosis Testing and Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Tuberculosis Testing and Diagnostics Revenue
3.4 Global Tuberculosis Testing and Diagnostics Market Concentration Ratio
3.4.1 Global Tuberculosis Testing and Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Tuberculosis Testing and Diagnostics Revenue in 2020
3.5 Tuberculosis Testing and Diagnostics Key Players Head office and Area Served
3.6 Key Players Tuberculosis Testing and Diagnostics Product Solution and Service
3.7 Date of Enter into Tuberculosis Testing and Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Tuberculosis Testing and Diagnostics Breakdown Data by Type
4.1 Global Tuberculosis Testing and Diagnostics Historic Market Size by Type (2016-2021)
4.2 Global Tuberculosis Testing and Diagnostics Forecasted Market Size by Type (2022-2027)

5 Tuberculosis Testing and Diagnostics Breakdown Data by Application
5.1 Global Tuberculosis Testing and Diagnostics Historic Market Size by Application (2016-2021)
5.2 Global Tuberculosis Testing and Diagnostics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Tuberculosis Testing and Diagnostics Market Size (2016-2027)
6.2 North America Tuberculosis Testing and Diagnostics Market Size by Type
6.2.1 North America Tuberculosis Testing and Diagnostics Market Size by Type (2016-2021)
6.2.2 North America Tuberculosis Testing and Diagnostics Market Size by Type (2022-2027)
6.2.3 North America Tuberculosis Testing and Diagnostics Market Size by Type (2016-2027)
6.3 North America Tuberculosis Testing and Diagnostics Market Size by Application
6.3.1 North America Tuberculosis Testing and Diagnostics Market Size by Application (2016-2021)
6.3.2 North America Tuberculosis Testing and Diagnostics Market Size by Application (2022-2027)
6.3.3 North America Tuberculosis Testing and Diagnostics Market Size by Application (2016-2027)
6.4 North America Tuberculosis Testing and Diagnostics Market Size by Country
6.4.1 North America Tuberculosis Testing and Diagnostics Market Size by Country (2016-2021)
6.4.2 North America Tuberculosis Testing and Diagnostics Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Tuberculosis Testing and Diagnostics Market Size (2016-2027)
7.2 Europe Tuberculosis Testing and Diagnostics Market Size by Type
7.2.1 Europe Tuberculosis Testing and Diagnostics Market Size by Type (2016-2021)
7.2.2 Europe Tuberculosis Testing and Diagnostics Market Size by Type (2022-2027)
7.2.3 Europe Tuberculosis Testing and Diagnostics Market Size by Type (2016-2027)
7.3 Europe Tuberculosis Testing and Diagnostics Market Size by Application
7.3.1 Europe Tuberculosis Testing and Diagnostics Market Size by Application (2016-2021)
7.3.2 Europe Tuberculosis Testing and Diagnostics Market Size by Application (2022-2027)
7.3.3 Europe Tuberculosis Testing and Diagnostics Market Size by Application (2016-2027)
7.4 Europe Tuberculosis Testing and Diagnostics Market Size by Country
7.4.1 Europe Tuberculosis Testing and Diagnostics Market Size by Country (2016-2021)
7.4.2 Europe Tuberculosis Testing and Diagnostics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Tuberculosis Testing and Diagnostics Market Size (2016-2027)
8.2 Asia-Pacific Tuberculosis Testing and Diagnostics Market Size by Type
8.2.1 Asia-Pacific Tuberculosis Testing and Diagnostics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Tuberculosis Testing and Diagnostics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Tuberculosis Testing and Diagnostics Market Size by Type (2016-2027)
8.3 Asia-Pacific Tuberculosis Testing and Diagnostics Market Size by Application
8.3.1 Asia-Pacific Tuberculosis Testing and Diagnostics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Tuberculosis Testing and Diagnostics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Tuberculosis Testing and Diagnostics Market Size by Application (2016-2027)
8.4 Asia-Pacific Tuberculosis Testing and Diagnostics Market Size by Region
8.4.1 Asia-Pacific Tuberculosis Testing and Diagnostics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Tuberculosis Testing and Diagnostics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Tuberculosis Testing and Diagnostics Market Size (2016-2027)
9.2 Latin America Tuberculosis Testing and Diagnostics Market Size by Type
9.2.1 Latin America Tuberculosis Testing and Diagnostics Market Size by Type (2016-2021)
9.2.2 Latin America Tuberculosis Testing and Diagnostics Market Size by Type (2022-2027)
9.2.3 Latin America Tuberculosis Testing and Diagnostics Market Size by Type (2016-2027)
9.3 Latin America Tuberculosis Testing and Diagnostics Market Size by Application
9.3.1 Latin America Tuberculosis Testing and Diagnostics Market Size by Application (2016-2021)
9.3.2 Latin America Tuberculosis Testing and Diagnostics Market Size by Application (2022-2027)
9.3.3 Latin America Tuberculosis Testing and Diagnostics Market Size by Application (2016-2027)
9.4 Latin America Tuberculosis Testing and Diagnostics Market Size by Country
9.4.1 Latin America Tuberculosis Testing and Diagnostics Market Size by Country (2016-2021)
9.4.2 Latin America Tuberculosis Testing and Diagnostics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Tuberculosis Testing and Diagnostics Market Size (2016-2027)
10.2 Middle East & Africa Tuberculosis Testing and Diagnostics Market Size by Type
10.2.1 Middle East & Africa Tuberculosis Testing and Diagnostics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Tuberculosis Testing and Diagnostics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Tuberculosis Testing and Diagnostics Market Size by Type (2016-2027)
10.3 Middle East & Africa Tuberculosis Testing and Diagnostics Market Size by Application
10.3.1 Middle East & Africa Tuberculosis Testing and Diagnostics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Tuberculosis Testing and Diagnostics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Tuberculosis Testing and Diagnostics Market Size by Application (2016-2027)
10.4 Middle East & Africa Tuberculosis Testing and Diagnostics Market Size by Country
10.4.1 Middle East & Africa Tuberculosis Testing and Diagnostics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Tuberculosis Testing and Diagnostics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche Tuberculosis Testing and Diagnostics Introduction
11.1.4 Roche Revenue in Tuberculosis Testing and Diagnostics Business (2016-2021)
11.1.5 Roche Recent Development
11.2 Thermo Fischer Scientific
11.2.1 Thermo Fischer Scientific Company Details
11.2.2 Thermo Fischer Scientific Business Overview
11.2.3 Thermo Fischer Scientific Tuberculosis Testing and Diagnostics Introduction
11.2.4 Thermo Fischer Scientific Revenue in Tuberculosis Testing and Diagnostics Business (2016-2021)
11.2.5 Thermo Fischer Scientific Recent Development
11.3 Becton Dickinson
11.3.1 Becton Dickinson Company Details
11.3.2 Becton Dickinson Business Overview
11.3.3 Becton Dickinson Tuberculosis Testing and Diagnostics Introduction
11.3.4 Becton Dickinson Revenue in Tuberculosis Testing and Diagnostics Business (2016-2021)
11.3.5 Becton Dickinson Recent Development
11.4 Abbott
11.4.1 Abbott Company Details
11.4.2 Abbott Business Overview
11.4.3 Abbott Tuberculosis Testing and Diagnostics Introduction
11.4.4 Abbott Revenue in Tuberculosis Testing and Diagnostics Business (2016-2021)
11.4.5 Abbott Recent Development
11.5 Hologic
11.5.1 Hologic Company Details
11.5.2 Hologic Business Overview
11.5.3 Hologic Tuberculosis Testing and Diagnostics Introduction
11.5.4 Hologic Revenue in Tuberculosis Testing and Diagnostics Business (2016-2021)
11.5.5 Hologic Recent Development
11.6 Qiagen
11.6.1 Qiagen Company Details
11.6.2 Qiagen Business Overview
11.6.3 Qiagen Tuberculosis Testing and Diagnostics Introduction
11.6.4 Qiagen Revenue in Tuberculosis Testing and Diagnostics Business (2016-2021)
11.6.5 Qiagen Recent Development
11.7 Sanofi
11.7.1 Sanofi Company Details
11.7.2 Sanofi Business Overview
11.7.3 Sanofi Tuberculosis Testing and Diagnostics Introduction
11.7.4 Sanofi Revenue in Tuberculosis Testing and Diagnostics Business (2016-2021)
11.7.5 Sanofi Recent Development
11.8 Oxford Immunotec
11.8.1 Oxford Immunotec Company Details
11.8.2 Oxford Immunotec Business Overview
11.8.3 Oxford Immunotec Tuberculosis Testing and Diagnostics Introduction
11.8.4 Oxford Immunotec Revenue in Tuberculosis Testing and Diagnostics Business (2016-2021)
11.8.5 Oxford Immunotec Recent Development
11.9 BioMerieux
11.9.1 BioMerieux Company Details
11.9.2 BioMerieux Business Overview
11.9.3 BioMerieux Tuberculosis Testing and Diagnostics Introduction
11.9.4 BioMerieux Revenue in Tuberculosis Testing and Diagnostics Business (2016-2021)
11.9.5 BioMerieux Recent Development
11.10 Par Sterile
11.10.1 Par Sterile Company Details
11.10.2 Par Sterile Business Overview
11.10.3 Par Sterile Tuberculosis Testing and Diagnostics Introduction
11.10.4 Par Sterile Revenue in Tuberculosis Testing and Diagnostics Business (2016-2021)
11.10.5 Par Sterile Recent Development
11.11 Bio-Rad Laboratories
11.11.1 Bio-Rad Laboratories Company Details
11.11.2 Bio-Rad Laboratories Business Overview
11.11.3 Bio-Rad Laboratories Tuberculosis Testing and Diagnostics Introduction
11.11.4 Bio-Rad Laboratories Revenue in Tuberculosis Testing and Diagnostics Business (2016-2021)
11.11.5 Bio-Rad Laboratories Recent Development
11.12 Akonni Biosystems
11.12.1 Akonni Biosystems Company Details
11.12.2 Akonni Biosystems Business Overview
11.12.3 Akonni Biosystems Tuberculosis Testing and Diagnostics Introduction
11.12.4 Akonni Biosystems Revenue in Tuberculosis Testing and Diagnostics Business (2016-2021)
11.12.5 Akonni Biosystems Recent Development
11.13 Cepheid
11.13.1 Cepheid Company Details
11.13.2 Cepheid Business Overview
11.13.3 Cepheid Tuberculosis Testing and Diagnostics Introduction
11.13.4 Cepheid Revenue in Tuberculosis Testing and Diagnostics Business (2016-2021)
11.13.5 Cepheid Recent Development
11.14 Siemens Healthineer
11.14.1 Siemens Healthineer Company Details
11.14.2 Siemens Healthineer Business Overview
11.14.3 Siemens Healthineer Tuberculosis Testing and Diagnostics Introduction
11.14.4 Siemens Healthineer Revenue in Tuberculosis Testing and Diagnostics Business (2016-2021)
11.14.5 Siemens Healthineer Recent Development
11.15 Hain Lifescience
11.15.1 Hain Lifescience Company Details
11.15.2 Hain Lifescience Business Overview
11.15.3 Hain Lifescience Tuberculosis Testing and Diagnostics Introduction
11.15.4 Hain Lifescience Revenue in Tuberculosis Testing and Diagnostics Business (2016-2021)
11.15.5 Hain Lifescience Recent Development
11.16 Epistem
11.16.1 Epistem Company Details
11.16.2 Epistem Business Overview
11.16.3 Epistem Tuberculosis Testing and Diagnostics Introduction
11.16.4 Epistem Revenue in Tuberculosis Testing and Diagnostics Business (2016-2021)
11.16.5 Epistem Recent Development
11.17 Creative Diagnostics
11.17.1 Creative Diagnostics Company Details
11.17.2 Creative Diagnostics Business Overview
11.17.3 Creative Diagnostics Tuberculosis Testing and Diagnostics Introduction
11.17.4 Creative Diagnostics Revenue in Tuberculosis Testing and Diagnostics Business (2016-2021)
11.17.5 Creative Diagnostics Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Tuberculosis Testing and Diagnostics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Smear Microscopy
Table 3. Key Players of Nucleic Acid Testing
Table 4. Key Players of Radiography
Table 5. Key Players of Tuberculin Skin Test (TST)
Table 6. Key Players of Interferon Gamma Released Assay (IGRA)
Table 7. Key Players of Others
Table 8. Global Tuberculosis Testing and Diagnostics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Tuberculosis Testing and Diagnostics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Tuberculosis Testing and Diagnostics Market Size by Regions (2016-2021) & (US$ Million)
Table 11. Global Tuberculosis Testing and Diagnostics Market Share by Regions (2016-2021)
Table 12. Global Tuberculosis Testing and Diagnostics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 13. Global Tuberculosis Testing and Diagnostics Market Share by Regions (2022-2027)
Table 14. Tuberculosis Testing and Diagnostics Market Trends
Table 15. Tuberculosis Testing and Diagnostics Market Drivers
Table 16. Tuberculosis Testing and Diagnostics Market Challenges
Table 17. Tuberculosis Testing and Diagnostics Market Restraints
Table 18. Global Tuberculosis Testing and Diagnostics Revenue by Players (2016-2021) & (US$ Million)
Table 19. Global Tuberculosis Testing and Diagnostics Market Share by Players (2016-2021)
Table 20. Global Top Tuberculosis Testing and Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Tuberculosis Testing and Diagnostics as of 2020)
Table 21. Ranking of Global Top Tuberculosis Testing and Diagnostics Companies by Revenue (US$ Million) in 2020
Table 22. Global 5 Largest Players Market Share by Tuberculosis Testing and Diagnostics Revenue (CR5 and HHI) & (2016-2021)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Tuberculosis Testing and Diagnostics Product Solution and Service
Table 25. Date of Enter into Tuberculosis Testing and Diagnostics Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Tuberculosis Testing and Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 28. Global Tuberculosis Testing and Diagnostics Revenue Market Share by Type (2016-2021)
Table 29. Global Tuberculosis Testing and Diagnostics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 30. Global Tuberculosis Testing and Diagnostics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 31. Global Tuberculosis Testing and Diagnostics Market Size Share by Application (2016-2021) & (US$ Million)
Table 32. Global Tuberculosis Testing and Diagnostics Revenue Market Share by Application (2016-2021)
Table 33. Global Tuberculosis Testing and Diagnostics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 34. Global Tuberculosis Testing and Diagnostics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 35. North America Tuberculosis Testing and Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 36. North America Tuberculosis Testing and Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 37. North America Tuberculosis Testing and Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 38. North America Tuberculosis Testing and Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 39. North America Tuberculosis Testing and Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 40. North America Tuberculosis Testing and Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 41. Europe Tuberculosis Testing and Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 42. Europe Tuberculosis Testing and Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 43. Europe Tuberculosis Testing and Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 44. Europe Tuberculosis Testing and Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 45. Europe Tuberculosis Testing and Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 46. Europe Tuberculosis Testing and Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Tuberculosis Testing and Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 48. Asia-Pacific Tuberculosis Testing and Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Tuberculosis Testing and Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 50. Asia-Pacific Tuberculosis Testing and Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Tuberculosis Testing and Diagnostics Market Size by Region (2016-2021) & (US$ Million)
Table 52. Asia-Pacific Tuberculosis Testing and Diagnostics Market Size by Region (2022-2027) & (US$ Million)
Table 53. Latin America Tuberculosis Testing and Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 54. Latin America Tuberculosis Testing and Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 55. Latin America Tuberculosis Testing and Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 56. Latin America Tuberculosis Testing and Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 57. Latin America Tuberculosis Testing and Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 58. Latin America Tuberculosis Testing and Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Tuberculosis Testing and Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 60. Middle East & Africa Tuberculosis Testing and Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Tuberculosis Testing and Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 62. Middle East & Africa Tuberculosis Testing and Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Tuberculosis Testing and Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 64. Middle East & Africa Tuberculosis Testing and Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 65. Roche Company Details
Table 66. Roche Business Overview
Table 67. Roche Tuberculosis Testing and Diagnostics Product
Table 68. Roche Revenue in Tuberculosis Testing and Diagnostics Business (2016-2021) & (US$ Million)
Table 69. Roche Recent Development
Table 70. Thermo Fischer Scientific Company Details
Table 71. Thermo Fischer Scientific Business Overview
Table 72. Thermo Fischer Scientific Tuberculosis Testing and Diagnostics Product
Table 73. Thermo Fischer Scientific Revenue in Tuberculosis Testing and Diagnostics Business (2016-2021) & (US$ Million)
Table 74. Thermo Fischer Scientific Recent Development
Table 75. Becton Dickinson Company Details
Table 76. Becton Dickinson Business Overview
Table 77. Becton Dickinson Tuberculosis Testing and Diagnostics Product
Table 78. Becton Dickinson Revenue in Tuberculosis Testing and Diagnostics Business (2016-2021) & (US$ Million)
Table 79. Becton Dickinson Recent Development
Table 80. Abbott Company Details
Table 81. Abbott Business Overview
Table 82. Abbott Tuberculosis Testing and Diagnostics Product
Table 83. Abbott Revenue in Tuberculosis Testing and Diagnostics Business (2016-2021) & (US$ Million)
Table 84. Abbott Recent Development
Table 85. Hologic Company Details
Table 86. Hologic Business Overview
Table 87. Hologic Tuberculosis Testing and Diagnostics Product
Table 88. Hologic Revenue in Tuberculosis Testing and Diagnostics Business (2016-2021) & (US$ Million)
Table 89. Hologic Recent Development
Table 90. Qiagen Company Details
Table 91. Qiagen Business Overview
Table 92. Qiagen Tuberculosis Testing and Diagnostics Product
Table 93. Qiagen Revenue in Tuberculosis Testing and Diagnostics Business (2016-2021) & (US$ Million)
Table 94. Qiagen Recent Development
Table 95. Sanofi Company Details
Table 96. Sanofi Business Overview
Table 97. Sanofi Tuberculosis Testing and Diagnostics Product
Table 98. Sanofi Revenue in Tuberculosis Testing and Diagnostics Business (2016-2021) & (US$ Million)
Table 99. Sanofi Recent Development
Table 100. Oxford Immunotec Company Details
Table 101. Oxford Immunotec Business Overview
Table 102. Oxford Immunotec Revenue in Tuberculosis Testing and Diagnostics Business (2016-2021) & (US$ Million)
Table 103. Oxford Immunotec Recent Development
Table 104. BioMerieux Company Details
Table 105. BioMerieux Business Overview
Table 106. BioMerieux Tuberculosis Testing and Diagnostics Product
Table 107. BioMerieux Revenue in Tuberculosis Testing and Diagnostics Business (2016-2021) & (US$ Million)
Table 108. BioMerieux Recent Development
Table 109. Par Sterile Company Details
Table 110. Par Sterile Business Overview
Table 111. Par Sterile Tuberculosis Testing and Diagnostics Product
Table 112. Par Sterile Revenue in Tuberculosis Testing and Diagnostics Business (2016-2021) & (US$ Million)
Table 113. Par Sterile Recent Development
Table 114. Bio-Rad Laboratories Company Details
Table 115. Bio-Rad Laboratories Business Overview
Table 116. Bio-Rad Laboratories Tuberculosis Testing and Diagnostics Product
Table 117. Bio-Rad Laboratories Revenue in Tuberculosis Testing and Diagnostics Business (2016-2021) & (US$ Million)
Table 118. Bio-Rad Laboratories Recent Development
Table 119. Akonni Biosystems Company Details
Table 120. Akonni Biosystems Business Overview
Table 121. Akonni Biosystems Tuberculosis Testing and Diagnostics Product
Table 122. Akonni Biosystems Revenue in Tuberculosis Testing and Diagnostics Business (2016-2021) & (US$ Million)
Table 123. Akonni Biosystems Recent Development
Table 124. Cepheid Company Details
Table 125. Cepheid Business Overview
Table 126. Cepheid Tuberculosis Testing and Diagnostics Product
Table 127. Cepheid Revenue in Tuberculosis Testing and Diagnostics Business (2016-2021) & (US$ Million)
Table 128. Cepheid Recent Development
Table 129. Siemens Healthineer Company Details
Table 130. Siemens Healthineer Business Overview
Table 131. Siemens Healthineer Tuberculosis Testing and Diagnostics Product
Table 132. Siemens Healthineer Revenue in Tuberculosis Testing and Diagnostics Business (2016-2021) & (US$ Million)
Table 133. Siemens Healthineer Recent Development
Table 134. Hain Lifescience Company Details
Table 135. Hain Lifescience Business Overview
Table 136. Hain Lifescience Tuberculosis Testing and Diagnostics Product
Table 137. Hain Lifescience Revenue in Tuberculosis Testing and Diagnostics Business (2016-2021) & (US$ Million)
Table 138. Hain Lifescience Recent Development
Table 139. Epistem Company Details
Table 140. Epistem Business Overview
Table 141. Epistem Tuberculosis Testing and Diagnostics Product
Table 142. Epistem Revenue in Tuberculosis Testing and Diagnostics Business (2016-2021) & (US$ Million)
Table 143. Epistem Recent Development
Table 144. Creative Diagnostics Company Details
Table 145. Creative Diagnostics Business Overview
Table 146. Creative Diagnostics Tuberculosis Testing and Diagnostics Product
Table 147. Creative Diagnostics Revenue in Tuberculosis Testing and Diagnostics Business (2016-2021) & (US$ Million)
Table 148. Creative Diagnostics Recent Development
Table 149. Research Programs/Design for This Report
Table 150. Key Data Information from Secondary Sources
Table 151. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Tuberculosis Testing and Diagnostics Market Share by Type: 2020 VS 2027
Figure 2. Smear Microscopy Features
Figure 3. Nucleic Acid Testing Features
Figure 4. Radiography Features
Figure 5. Tuberculin Skin Test (TST) Features
Figure 6. Interferon Gamma Released Assay (IGRA) Features
Figure 7. Others Features
Figure 8. Global Tuberculosis Testing and Diagnostics Market Share by Application: 2020 VS 2027
Figure 9. Hospitals and Clinics Case Studies
Figure 10. Diagnostic Laboratories Case Studies
Figure 11. Others Case Studies
Figure 12. Tuberculosis Testing and Diagnostics Report Years Considered
Figure 13. Global Tuberculosis Testing and Diagnostics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 14. Global Tuberculosis Testing and Diagnostics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Tuberculosis Testing and Diagnostics Market Share by Regions: 2020 VS 2027
Figure 16. Global Tuberculosis Testing and Diagnostics Market Share by Regions (2022-2027)
Figure 17. Global Tuberculosis Testing and Diagnostics Market Share by Players in 2020
Figure 18. Global Top Tuberculosis Testing and Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Tuberculosis Testing and Diagnostics as of 2020
Figure 19. The Top 10 and 5 Players Market Share by Tuberculosis Testing and Diagnostics Revenue in 2020
Figure 20. Global Tuberculosis Testing and Diagnostics Revenue Market Share by Type (2016-2021)
Figure 21. Global Tuberculosis Testing and Diagnostics Revenue Market Share by Type (2022-2027)
Figure 22. North America Tuberculosis Testing and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. North America Tuberculosis Testing and Diagnostics Market Share by Type (2016-2027)
Figure 24. North America Tuberculosis Testing and Diagnostics Market Share by Application (2016-2027)
Figure 25. North America Tuberculosis Testing and Diagnostics Market Share by Country (2016-2027)
Figure 26. United States Tuberculosis Testing and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Canada Tuberculosis Testing and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Tuberculosis Testing and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Tuberculosis Testing and Diagnostics Market Share by Type (2016-2027)
Figure 30. Europe Tuberculosis Testing and Diagnostics Market Share by Application (2016-2027)
Figure 31. Europe Tuberculosis Testing and Diagnostics Market Share by Country (2016-2027)
Figure 32. Germany Tuberculosis Testing and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. France Tuberculosis Testing and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. U.K. Tuberculosis Testing and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Italy Tuberculosis Testing and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Russia Tuberculosis Testing and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Nordic Tuberculosis Testing and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Tuberculosis Testing and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Tuberculosis Testing and Diagnostics Market Share by Type (2016-2027)
Figure 40. Asia-Pacific Tuberculosis Testing and Diagnostics Market Share by Application (2016-2027)
Figure 41. Asia-Pacific Tuberculosis Testing and Diagnostics Market Share by Region (2016-2027)
Figure 42. China Tuberculosis Testing and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Japan Tuberculosis Testing and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. South Korea Tuberculosis Testing and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Southeast Asia Tuberculosis Testing and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. India Tuberculosis Testing and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Australia Tuberculosis Testing and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Tuberculosis Testing and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Tuberculosis Testing and Diagnostics Market Share by Type (2016-2027)
Figure 50. Latin America Tuberculosis Testing and Diagnostics Market Share by Application (2016-2027)
Figure 51. Latin America Tuberculosis Testing and Diagnostics Market Share by Country (2016-2027)
Figure 52. Mexico Tuberculosis Testing and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Brazil Tuberculosis Testing and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Tuberculosis Testing and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Tuberculosis Testing and Diagnostics Market Share by Type (2016-2027)
Figure 56. Middle East & Africa Tuberculosis Testing and Diagnostics Market Share by Application (2016-2027)
Figure 57. Middle East & Africa Tuberculosis Testing and Diagnostics Market Share by Country (2016-2027)
Figure 58. Turkey Tuberculosis Testing and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Saudi Arabia Tuberculosis Testing and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. UAE Tuberculosis Testing and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Roche Revenue Growth Rate in Tuberculosis Testing and Diagnostics Business (2016-2021)
Figure 62. Thermo Fischer Scientific Revenue Growth Rate in Tuberculosis Testing and Diagnostics Business (2016-2021)
Figure 63. Becton Dickinson Revenue Growth Rate in Tuberculosis Testing and Diagnostics Business (2016-2021)
Figure 64. Abbott Revenue Growth Rate in Tuberculosis Testing and Diagnostics Business (2016-2021)
Figure 65. Hologic Revenue Growth Rate in Tuberculosis Testing and Diagnostics Business (2016-2021)
Figure 66. Qiagen Revenue Growth Rate in Tuberculosis Testing and Diagnostics Business (2016-2021)
Figure 67. Sanofi Revenue Growth Rate in Tuberculosis Testing and Diagnostics Business (2016-2021)
Figure 68. Oxford Immunotec Revenue Growth Rate in Tuberculosis Testing and Diagnostics Business (2016-2021)
Figure 69. BioMerieux Revenue Growth Rate in Tuberculosis Testing and Diagnostics Business (2016-2021)
Figure 70. Par Sterile Revenue Growth Rate in Tuberculosis Testing and Diagnostics Business (2016-2021)
Figure 71. Bio-Rad Laboratories Revenue Growth Rate in Tuberculosis Testing and Diagnostics Business (2016-2021)
Figure 72. Akonni Biosystems Revenue Growth Rate in Tuberculosis Testing and Diagnostics Business (2016-2021)
Figure 73. Cepheid Revenue Growth Rate in Tuberculosis Testing and Diagnostics Business (2016-2021)
Figure 74. Siemens Healthineer Revenue Growth Rate in Tuberculosis Testing and Diagnostics Business (2016-2021)
Figure 75. Hain Lifescience Revenue Growth Rate in Tuberculosis Testing and Diagnostics Business (2016-2021)
Figure 76. Epistem Revenue Growth Rate in Tuberculosis Testing and Diagnostics Business (2016-2021)
Figure 77. Creative Diagnostics Revenue Growth Rate in Tuberculosis Testing and Diagnostics Business (2016-2021)
Figure 78. Bottom-up and Top-down Approaches for This Report
Figure 79. Data Triangulation
Figure 80. Key Executives Interviewed